BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18087027)

  • 1. Docetaxel monotherapy for angiosarcoma in an elderly patient.
    Nagano T; Tai Y; Higashida Y; Fujiwara N; Oka M; Nishigori C
    Arch Dermatol; 2007 Dec; 143(12):1602-3. PubMed ID: 18087027
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term metronomic docetaxel chemotherapy for inoperative angiosarcoma of the scalp.
    Sumikawa Y; Inui S; Nishimura Y; Morita E; Kurachi K
    J Dermatol; 2011 Apr; 38(4):393-5. PubMed ID: 21352341
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel.
    Nakamura Y; Nakamura Y; Hori E; Furuta J; Kawachi Y; Otsuka F
    Br J Dermatol; 2010 Dec; 163(6):1357-8. PubMed ID: 20731655
    [No Abstract]   [Full Text] [Related]  

  • 4. Durable response of angiosarcoma of the face and scalp to docetaxel.
    Veliz M; Chang V; Kasimis B; Choe JK
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):210. PubMed ID: 17359910
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib.
    Ono S; Tanioka M; Fujisawa A; Tanizaki H; Miyachi Y; Matsumura Y
    Arch Dermatol; 2012 Jun; 148(6):683-5. PubMed ID: 22710450
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiosarcoma of the scalp and face: failure of an interferon alpha treatment.
    Guillot B; Raison-Peyron N; Acevedo M; Meunier L; Dandurand M; Meynadier J
    Eur J Dermatol; 2000 Jun; 10(4):300-2. PubMed ID: 10846259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of angiosarcoma of the scalp with severe fluid retention after administering docetaxel].
    Namba R; Kanazawa J; Yamamoto Y; Itou S; Nawa T
    Gan To Kagaku Ryoho; 2011 May; 38(5):807-10. PubMed ID: 21566442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients.
    Nagano T; Yamada Y; Ikeda T; Kanki H; Kamo T; Nishigori C
    Cancer; 2007 Aug; 110(3):648-51. PubMed ID: 17582627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiosarcoma of the scalp treated with OK-432 and rIL-2.
    Miura H; Inui S; Sakai H; Hasebe N; Itami S; Yoshikawa K
    Int J Dermatol; 2002 May; 41(5):286-8. PubMed ID: 12100706
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel.
    Isogai R; Kawada A; Aragane Y; Tezuka T
    J Dermatol; 2004 Apr; 31(4):335-41. PubMed ID: 15187330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen.
    Shkoukani MA; Carron MA; Tulunay O; Kucuk O; Lin HS
    Ear Nose Throat J; 2011 Jan; 90(1):E26-9. PubMed ID: 21229496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission of treatment-refractory advanced angiosarcoma of the scalp by protracted intralesional interleukin-2 therapy.
    Gebhardt C; Ziegler B; Stadler S; Goerdt S; Utikal J
    Br J Dermatol; 2015 Apr; 172(4):1156-8. PubMed ID: 25204400
    [No Abstract]   [Full Text] [Related]  

  • 13. Partial response of angiosarcoma of the scalp to sorafenib: association with decreased expression of vascular endothelial growth factors and their receptors.
    Tamiya H; Kamo R; Kumei A; Yanagihara S; Ishii M; Kobayashi H
    Clin Exp Dermatol; 2012 Oct; 37(7):749-52. PubMed ID: 22369131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunosuppressive and cytotoxic cells in angiosarcoma: development of a possible supportive therapy for angiosarcoma.
    Kambayashi Y; Fujimura T; Furudate S; Hashimoto A; Haga T; Aiba S
    Dermatology; 2013; 227(1):14-20. PubMed ID: 23867803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazopanib: an alternative in taxane-resistant cutaneous angiosarcoma.
    Fujita M; Endo Y; Fujisawa A; Tanioka M; Kabashima K; Miyachi Y
    Eur J Dermatol; 2014; 24(2):267-8. PubMed ID: 24682601
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful treatment of angiosarcoma with liposomal-encapsulated doxorubicin].
    Voss A; Seitz CS; Rose C; Bröcker EB; Goebeler M
    Hautarzt; 2001 Oct; 52(10):895-8. PubMed ID: 17690822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiosarcoma of the scalp responding to nivolumab: a case report.
    Hofer S; Zeidler K; Schipf A; Kempf W; Zimmermann D; Aebi S
    Br J Dermatol; 2018 Aug; 179(2):530-531. PubMed ID: 29700818
    [No Abstract]   [Full Text] [Related]  

  • 18. [Retrograde intravenous perfusion with cytostatic drugs in angiosarcoma].
    Feuerstein P; Steiner A; Partsch H
    Wien Med Wochenschr; 1993; 143(7-8):204-6. PubMed ID: 8379179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cardiac angiosarcoma with radiation and docetaxel: a case report with partial response and prolonged stable disease.
    Suderman D; Cooke A; Wong R; Klein J
    J Thorac Oncol; 2011 Apr; 6(4):834-5. PubMed ID: 21623260
    [No Abstract]   [Full Text] [Related]  

  • 20. Pazopanib can preserve cosmetic quality of life even in end-stage angiosarcoma.
    Kitamura S; Hata H; Imafuku K; Haga N; Homma E; Shimizu H
    Clin Exp Dermatol; 2015 Dec; 40(8):931-3. PubMed ID: 25817046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.